Skip to main content

Table 4 Patient characteristics

From: Effectiveness of pharmaceutical support by pharmacists in urinary care teams

 

Adoption n = 20

 

Non- adoption n = 8

 

p-value

Agea

85.5

(80.0–90.3)

80.5

(77.8–85.6)

0.328b

Sex (male/female)

11/9

 

2/6

 

0.221c

Primary disease

Femoral fracture

7

 

4

 

–

Cerebrovascular disease

3

 

1

  

Heart failure

1

 

1

  

Orthopedics

1

 

1

  

Pneumothorax

1

 

0

  

Prostate cancer

1

 

0

  

Cellulitis

1

 

0

  

Endometriosis

1

 

0

  

Pulmonary embolism

1

 

0

  

Gastritis

1

 

0

  

Heart stroke

1

 

0

  

Fever of unknown origin

1

 

0

  

Aspiration pneumonia

0

 

1

  

Hospital stay duration (days)

Overalla

39.0

(30.0–47.3)

39.5

(31.0–48.6)

0.5001

After intervention of urinary care teama

22.5

(19.5–31.0)

22.0

(20.0–29.0)

0.636b

Score

Total score of urinary functiona

13.0

(9.5–14.0)

11.5

(10.0–13.3)

0.746b

Degree of independence of urinationa

8.0

(5.0–10.0)

7.0

(5.5–8.0)

0.381b

Score of lower urinary tract disordera

4.0

(3.0–5.0)

4.0

(4.0–6.3)

0.381b

Urinary situation

Intermittent urethral catheterization

17

 

6

 

0.391d

Urinary incontinence

1

 

0

  

Use of nursing care diaper

1

 

2

  

Continuous urethral catheter

1

 

0

  
  1. aMedian (interquartile range; IQR)
  2. bMann-Whiteny U test
  3. cFisher Exact test
  4. dPearson χ2 test